Preview
A patient at Shanghai’s Huashan Hospital received the world’s first commercial implant of a regulator-approved invasive BCI on July 13 using Neuracle Technology’s NEO system, which decodes epidural signals to restore hand mobility via external devices. The…
The complete summary, “why it matters” analysis and the original source link are available to members.
BCINeural ImplantClinical TrialMotor Control